![Peter de Waele](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter de Waele
Directeur Général chez
Advanced Therapies Consulting Limited
Profil
Peter de Waele is the founder of Xcellentis NV, which was founded in 2001, where he held the title of Chief Operating Officer in 2006.
He is currently the Managing Director at Advanced Therapies Consulting Limited.
Dr. de Waele's former positions include Chief Therapeutics Officer at Fujirebio Europe NV, Assistant Professor at Ghent University in 1986, and Vice President-Research & Development at Celyad Oncology SA from 2010 to 2017.
Dr. de Waele received his graduate and doctorate degrees from Ghent University.
Postes actifs de Peter de Waele
| Sociétés | Poste | Début |
|---|---|---|
Advanced Therapies Consulting Limited | Directeur Général | - |
Anciens postes connus de Peter de Waele
| Sociétés | Poste | Fin |
|---|---|---|
| CELYAD ONCOLOGY SA | Directeur Technique/Scientifique/R&D | - |
Xcellentis NV
 Xcellentis NV Pharmaceuticals: MajorHealth Technology Develops clinical stage pipeline products for the treatment of chronic, hard-to-heal wounds | Fondateur | 01/01/2006 |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1986 |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Develops and markets diagnostic products to improve therapy management and patient health | Corporate Officer/Principal | - |
Formation de Peter de Waele
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
21
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Develops and markets diagnostic products to improve therapy management and patient health | Health Technology |
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xcellentis NV
Xcellentis NV Pharmaceuticals: MajorHealth Technology Develops clinical stage pipeline products for the treatment of chronic, hard-to-heal wounds | Health Technology |
Celyad Oncology SA
 Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Advanced Therapies Consulting Limited |
